MaxCyte Signs Strategic Platform License with Be Biopharma

Be Biopharma to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform within its Engineered B Cell Medicines programs...

Related Keywords

United Kingdom ,Anya Bolshem ,Chris Welsh ,Maher Masoud ,David Deuchler ,Bio Bcms ,Richard James ,Panmure Gordon ,Mary Jane Elliott ,Emma Earl Freddy Crossley ,Rupert Dearden ,David Rawlings ,Seattle Children Research Institute ,Nasdaq ,Bristol Myers Squibb ,Maxcyte Inc ,Twitter ,Longwood Fund ,Gilmartin Group ,Linkedin ,Atlas Venture ,Engineeredb Cell Medicines ,Seattle Children ,Alta Partners ,Takeda Ventures ,Research Institute ,Cyte Contacts ,Joint Corporate ,Bio Contacts ,Nasdaq Mxct ,Maxcyte ,Nc ,